Marlies M Kok
Overview
Explore the profile of Marlies M Kok including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
426
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Vliet D, Ploumen E, Pinxterhuis T, Doggen C, Aminian A, Schotborgh C, et al.
Clin Res Cardiol
. 2025 Mar;
PMID: 40035811
Background: Percutaneous coronary intervention (PCI) with new-generation drug-eluting stents is increasingly performed in elderly patients, who generally have more comorbidities and more technically challenging target lesions. Nevertheless, there is a...
2.
Sex and age-specific 10-year mortality after coronary stenting: an analysis of two randomized trials
Pinxterhuis T, Ploumen E, Doggen C, van Vliet D, Kok M, Zocca P, et al.
Eur Heart J Open
. 2025 Feb;
5(1):oeaf006.
PMID: 39959922
Aims: Over time, clinical outcome after percutaneous coronary intervention (PCI) with contemporary drug-eluting stents (DES) has improved. While most patients survive for many years after PCI, data on potential sex...
3.
Pinxterhuis T, Ploumen E, Kok M, Schotborgh C, Anthonio R, Roguin A, et al.
Cardiovasc Interv Ther
. 2024 Dec;
40(2):287-295.
PMID: 39699832
Patients undergoing percutaneous coronary intervention (PCI) may experience bleeding events. Bleeding risk is increased in patients with comorbid peripheral arterial disease (PADs). To evaluate whether PCI patients with PADs have...
4.
Ploumen E, Pinxterhuis T, Buiten R, Zocca P, Danse P, Schotborgh C, et al.
J Am Heart Assoc
. 2022 Nov;
11(22):e026041.
PMID: 36346050
Background In a previous trial, higher 5-year mortality was observed following treatment with biodegradable polymer Orsiro sirolimus-eluting stents (SES). We assessed 5-year safety and efficacy of all-comers as well as...
5.
Ploumen E, Pinxterhuis T, Zocca P, Roguin A, Anthonio R, Schotborgh C, et al.
Cardiovasc Diabetol
. 2021 Oct;
20(1):217.
PMID: 34717627
Background: Diabetes is associated with adverse outcomes after percutaneous coronary intervention with drug-eluting stents (DES), but for prediabetes this association has not been definitely established. Furthermore, in patients with prediabetes...
6.
Ploumen E, Buiten R, Zocca P, Doggen C, Jessurun G, Schotborgh C, et al.
Catheter Cardiovasc Interv
. 2021 Mar;
98(2):E188-E196.
PMID: 33694294
Objectives: To compare 2-year outcome following treatment with drug-eluting stents (DES) for acute myocardial infarction (MI) versus non-MI clinical syndromes. In acute MI patients, a stent-level comparison was performed, comparing...
7.
Ploumen E, Buiten R, Kok M, Doggen C, Roguin A, Jessurun G, et al.
Int J Cardiol
. 2020 Nov;
325:37-44.
PMID: 33148427
Background: Patients with diabetes have more extensive coronary disease, resulting in higher risks of adverse clinical events following stenting. In all-comer patients, contemporary DES have shown excellent safety and efficacy,...
8.
Ploumen E, Buiten R, Doggen C, Stoel M, van Houwelingen K, Schotborgh C, et al.
Am Heart J
. 2020 Sep;
228:109-115.
PMID: 32882569
Background: Patients aged ≥80 years are often treated with new-generation drug-eluting stents (DES), but data from randomized studies are scarce owing to underrepresentation in most trials. We assessed 1-year clinical...
9.
Chandrasekhar J, Kok M, Kalkman D, Aquino M, Zocca P, Woudstra P, et al.
JACC Cardiovasc Interv
. 2020 Apr;
13(7):820-830.
PMID: 32273094
Objectives: The aim of this study was to determine 1-year safety and efficacy after treatment with the COMBO and Orsiro stents. Background: The COMBO stainless-steel stent has an anti-CD34 antibody...
10.
Kok M, von Birgelen C
EuroIntervention
. 2020 Feb;
15(14):1228-1231.
PMID: 32044732
No abstract available.